Lucid Diagnostics (LUCD) Shares Issued (2020 - 2026)

Lucid Diagnostics (LUCD) has 6 years of Shares Issued data on file, last reported at $20000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued fell 85.82% year-over-year to $20000.0; the trailing twelve-month figure through Mar 2026 stood at -$43.0 million (down 2694.63% YoY), and the FY2025 full-year result was $17000.0, down 99.06% from the prior year.
• Shares Issued for Q1 2026 stood at $20000.0, up from -$43.2 million in the prior quarter.
• Across five years, Shares Issued topped out at $1.8 million in Q2 2025 and bottomed at -$43.2 million in Q4 2025.
• The 5-year median for Shares Issued is $141000.0 (2025), against an average of -$3.1 million.
• The widest annual swing landed in 2023, when Shares Issued surged 51.87%; it then plunged 93.8% in 2024.
• A 5-year view of Shares Issued shows it stood at -$1.1 million in 2022, then jumped by 236.33% to $1.5 million in 2023, then slumped by 93.8% to $94000.0 in 2024, then plunged by 46008.51% to -$43.2 million in 2025, then jumped by 100.05% to $20000.0 in 2026.
• The last three Shares Issued figures came in at $20000.0 (Q1 2026), -$43.2 million (Q4 2025), and $131000.0 (Q3 2025), per Business Quant data.

Peer Comparison